ArticleSexually transmitted diseases2026
Early Third-Trimester Syphilis Screening Adherence Among Medicaid Recipients in New York City, 2020-2022.
Article in Sexually transmitted diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn November 2019, New York City (NYC) mandated universal syphilis screening during pregnancy at 28 to 32 weeks' gestation (early third-trimester syphilis screening [ETTSS]) for congenital syphilis prevention. Medicaid is a significant payer for pregnancy-related and sexually transmitted infection care in NYC. We examined adherence to, and disparities in, ETTSS among pregnancies of NYC Medicaid recipients from 2020 to 2022.
methodsWe used Medicaid claims data to identify pregnancies using International Classification of Diseases, Tenth Revision codes related to delivery outcome and gestational age. We included people at least 12 years old with birth events at ≥33 weeks' gestation, and enrollment in Medicaid for the entire pregnancy. We identified syphilis screening using Current Procedural Terminology codes and enumerated screening timelines. Using log-binomial regression, we calculated adjusted prevalence ratios (aPR) for ETTSS by race/ethnicity, birth outcome, county of residence, and neighborhood poverty level.
resultsOf 105,092 pregnancies, 29.7% (31,193 of 105,092) received ETTSS. The proportion of pregnancies that received ETTSS increased from 29.4% (8925 of 30,396) in 2020 to 30.0% (11,656 of 38,859) in 2022 ( P = 0.03). Compared with Hispanic persons, ETTSS was lower in Non-Hispanic (NH) Asian/Pacific Islander (aPR, 0.89; confidence interval [CI], 0.86-0.92), NH-Black (aPR, 0.90; CI, 0.88-0.93), NH-White (aPR, 0.76; CI, 0.74-0.79), and NH-Other race (aPR, 0.80; CI, 0.77-0.83) groups. Early third-trimester syphilis screening was higher among pregnant people living in high/very-high-poverty neighborhoods compared with those in low/medium-poverty neighborhoods (aPR, 1.15; CI, 1.13-1.17).
conclusionsEarly third-trimester syphilis screening was performed in less than one-third of pregnancies, with differential screening levels by key sociodemographics. Monitoring ETTSS adherence over time is important to inform congenital syphilis prevention interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.